Estimating lifetime or episode-of-illness costs under censoring

Health Economics

Volumn 19, Issue 9, 2010, Pages 1010-1028

  Basu, Anirban ^a   Manning, Willard G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Censored costs; Episode of illness; Inverse probability weighting

Indexed keywords

CENSORSHIP; CONFERENCE PAPER; HEALTH CARE COST; MEDICARE; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; SIMULATION; SURVIVAL RATE; THEORETICAL MODEL;

COMORBIDITY; COMPUTER SIMULATION; COST OF ILLNESS; COSTS AND COST ANALYSIS; DATA INTERPRETATION, STATISTICAL; EPISODE OF CARE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MODELS, ECONOMIC; PROBABILITY; PROSTATIC NEOPLASMS; SEER PROGRAM; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 77956637581     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1640     Document Type: Conference Paper

References (22)

1. Bang H, Tsiatis AS. 2000. Estimating medical costs with censored data. Biometrika 87(2): 329-343.
2. Başer O, Gardiner JC, Bradley CJ, Given CW. 2004. Estimation from censored medical cost data. Biometrical Journal 46: 351-363.
3. Basu A, Rathouz PJ. 2005. Estimating incremental and marginal effects on health outcomes using flexible link and variance function models. Biostatistics 6(1): 93-109.
4. Blough DK, Madden CW, Hornbrook MC. 1999. Modeling risk using generalized linear models. Journal of Health Economics 18: 153-171.
5. Brown M, Riley GF, Schussler N, Etzioni R. 2002. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care 40(8 Suppl.): IV-104-117.
6. Carides GW, Heyse JF, Iglewicz B. 2001. A regression-based method for estimating mean treatment cost in the presence of right-censoring. Biostatistics 1: 299-313.
7. Duan N, Manning WG, Morris CN, Newhouse JP. 1983. A comparison of alternative models for the demand for medical care. Journal of Business and Economics Statistics 1: 115-126.
8. Etzioni R, Ramsey SD, Berry K, Brown M. 2001. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. Health Economics 10: 245-256.
9. Jones A. 2002. Health econometrics. In Handbook of Health Economics, Culyer A, Newhouse J (eds). Elsevier: Amsterdam.
10. Kurland BF, Heagerty PJ. 2005. Directly parameterized regression conditioning o being alive: analysis of longitudinal data truncated by deaths. Biostatistics 6(2): 241-258.
11. Lin DY. 2000a. Linear regression analysis of censored medical costs. Biostatistics 1(1): 35-47.
12. Lin DY. 2000b. Proportional means regression for censored medical costs. Biometrics 56(3): 775-778.
13. Lin DY. 2003. Regression analysis of incomplete medical cost data. Statistics in Medicine 22(7): 1181-1200.
14. Lin DY, Feuer EJ, Etzioni R, Wax Y. 1997. Estimating medical costs from incomplete follow-up data. Biometrics 53: 113-128.
15. Manning WG. 1998. The logged dependent variable, heteroscedasticity, and the retransformation problem. Journal of Health Economics 17: 283-295.
16. Meltzer DO, Egleston B, Abdalla I. 2001. Patterns of prostate cancer treatment by clinical stage and age in the United States. American Journal of Public Health 91(1): 126-128.
17. Mullahy J. 1998. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. Journal of Health Economics 17: 247-281.
18. O'Hagan A, Stevens JW. 2004. On estimators of medical costs with censored data. Journal of Health Economics 23: 615-625.
19. Pauler DK, McCoy S, Moinpour C. 2003. Pattern mixture models for longitudinal quality of life studies in advanced stage diseases. Statistics in Medicine 22: 795-809.
20. Pepe MS, Heagerty P, Whitaker R. 1999. Prediction using partly conditional time-varying coefficients regression models. Biometrics 55: 944-950.
21. Ribaudo HJ, Thomson SJ, Allen-Mersh TG. 2001. A joint analysis of quality of life and survival using a random effect selection model. Statistics in Medicine 20: 1173-1184.
22. Scitovsky AA. 1984. The high cost of dying': what do the data show? Milbank Memorial Fund Quarterly 62(4): 591-608.